Financial Comparison: Acreage (OTCMKTS:ACRGF) and Lifecore Biomedical (NASDAQ:LFCR)

Lifecore Biomedical (NASDAQ:LFCRGet Free Report) and Acreage (OTCMKTS:ACRGFGet Free Report) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, dividends, risk, profitability, valuation and earnings.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Lifecore Biomedical and Acreage, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Lifecore Biomedical 1 1 1 0 2.00
Acreage 0 0 0 0 0.00

Lifecore Biomedical currently has a consensus target price of $6.50, indicating a potential upside of 47.73%. Given Lifecore Biomedical’s stronger consensus rating and higher possible upside, research analysts plainly believe Lifecore Biomedical is more favorable than Acreage.

Earnings and Valuation

This table compares Lifecore Biomedical and Acreage”s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Lifecore Biomedical $128.87 million 1.29 -$40.50 million ($1.07) -4.11
Acreage N/A N/A N/A N/A N/A

Acreage has lower revenue, but higher earnings than Lifecore Biomedical.

Profitability

This table compares Lifecore Biomedical and Acreage’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Lifecore Biomedical -29.93% N/A -16.16%
Acreage N/A N/A N/A

Insider and Institutional Ownership

83.4% of Lifecore Biomedical shares are owned by institutional investors. 32.7% of Lifecore Biomedical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Lifecore Biomedical beats Acreage on 6 of the 8 factors compared between the two stocks.

About Lifecore Biomedical

(Get Free Report)

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. The company engages in the manufacturing of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.

About Acreage

(Get Free Report)

Acreage Holdings, Inc. engages in owning and operating cannabis licenses and assets in the U.S. with respect to the number of states with cannabis related licenses. It focuses on the cultivation, processing, and distribution operations. The company was founded by Kevin P. Murphy on July 12, 1989 and is headquartered in New York, NY.

Receive News & Ratings for Lifecore Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lifecore Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.